41 related articles for article (PubMed ID: 11911866)
1. Continuous Infusion of Phenelzine, Cyclosporine A, or Their Combination: Evaluation of Mitochondrial Bioenergetics, Oxidative Damage, and Cytoskeletal Degradation following Severe Controlled Cortical Impact Traumatic Brain Injury in Rats.
Kulbe JR; Singh IN; Wang JA; Cebak JE; Hall ED
J Neurotrauma; 2018 Jun; 35(11):1280-1293. PubMed ID: 29336204
[TBL] [Abstract][Full Text] [Related]
2. Reverse Electron Transport at Mitochondrial Complex I in Ischemic Stroke, Aging, and Age-Related Diseases.
Chavda V; Lu B
Antioxidants (Basel); 2023 Apr; 12(4):. PubMed ID: 37107270
[TBL] [Abstract][Full Text] [Related]
3. Effects of NXY-059 in experimental stroke: an individual animal meta-analysis.
Bath PM; Gray LJ; Bath AJ; Buchan A; Miyata T; Green AR;
Br J Pharmacol; 2009 Aug; 157(7):1157-71. PubMed ID: 19422398
[TBL] [Abstract][Full Text] [Related]
4. [Development of new stroke therapies: outlook for neuroprotective drugs].
Rogalewski A; Schäbitz WR
Nervenarzt; 2008 Feb; 79(2):218-24. PubMed ID: 18214414
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective effects of free radical scavengers in stroke.
Wang CX; Shuaib A
Drugs Aging; 2007; 24(7):537-46. PubMed ID: 17658905
[TBL] [Abstract][Full Text] [Related]
6. Reduction of mitochondrial electron transport complex activity is restricted to the ischemic focus after transient focal cerebral ischemia in rats: a histochemical volumetric analysis.
Christensen T; Diemer NH
Neurochem Res; 2003 Dec; 28(12):1805-12. PubMed ID: 14649721
[TBL] [Abstract][Full Text] [Related]
7. Development of the nitrone-based spin trap agent NXY-059 to treat acute ischemic stroke.
Lapchak PA; Araujo DM
CNS Drug Rev; 2003; 9(3):253-62. PubMed ID: 14530797
[TBL] [Abstract][Full Text] [Related]
8. Nitrone-related therapeutics: potential of NXY-059 for the treatment of acute ischaemic stroke.
Maples KR; Green AR; Floyd RA
CNS Drugs; 2004; 18(15):1071-84. PubMed ID: 15581379
[TBL] [Abstract][Full Text] [Related]
9. Effect of NXY-059 on secondary mitochondrial dysfunction after transient focal ischemia; comparison with cyclosporin A.
Yoshimoto T; Kristián T; Hu B; Ouyang YB; Siesjö BK
Brain Res; 2002 Apr; 932(1-2):99-109. PubMed ID: 11911866
[TBL] [Abstract][Full Text] [Related]
10. The immunosuppressant drug FK506 ameliorates secondary mitochondrial dysfunction following transient focal cerebral ischemia in the rat.
Nakai A; Kuroda S; Kristián T; Siesjö BK
Neurobiol Dis; 1997; 4(3-4):288-300. PubMed ID: 9361306
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective effects of a novel nitrone, NXY-059, after transient focal cerebral ischemia in the rat.
Kuroda S; Tsuchidate R; Smith ML; Maples KR; Siesjö BK
J Cereb Blood Flow Metab; 1999 Jul; 19(7):778-87. PubMed ID: 10413033
[TBL] [Abstract][Full Text] [Related]
12. Cyclosporin A, but not FK506, prevents the downregulation of phosphorylated Akt after transient focal ischemia in the rat.
Yoshimoto T; Uchino H; He QP; Li PA; Siesjö BK
Brain Res; 2001 Apr; 899(1-2):148-58. PubMed ID: 11311876
[TBL] [Abstract][Full Text] [Related]
13. NXY-059, a nitrone with free radical trapping properties inhibits release of cytochrome c after focal cerebral ischemia.
Han M; He QP; Yong G; Siesjö BK; Li PA
Cell Mol Biol (Noisy-le-grand); 2003 Dec; 49(8):1249-52. PubMed ID: 14983994
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
